Relationship Between Pulmonary Arterial Resistance and Compliance in Patients with Down Syndrome

Yuka Iwaya1, Jun Muneuchi2, Yuka Inoue1

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Japan Community Healthcare Organization, Kyushu Hospital, 1-8-1, Kishinoura, Yahatanishiku, Kitakyushu, Fukuoka, 806-8501, Japan.

Pediatric Cardiology
|March 5, 2019
PubMed

Insights

Individuals with Down syndrome (DS) exhibit unique pulmonary vasculature with lower pulmonary compliance (Cp). This low Cp is linked to the need for postoperative home oxygen therapy (HOT) in DS infants after corrective surgery for congenital heart disease.

Area of Science:

  • Cardiology
  • Pediatrics
  • Pulmonology

Background:

  • Down syndrome (DS) is associated with an increased risk of pulmonary arterial hypertension (PAH).
  • Pulmonary arterial resistance (Rp)-compliance (Cp) coupling is crucial for cardiovascular health.
  • Understanding pulmonary vascular characteristics in DS is vital for managing PAH risk.

Purpose of the Study:

  • To investigate the pulmonary arterial resistance (Rp)-compliance (Cp) coupling in infants with Down syndrome (DS).
  • To compare hemodynamic parameters before and after corrective surgery in DS infants and controls with congenital heart disease and PAH.
  • To identify factors associated with postoperative outcomes in DS patients.

Main Methods:

  • Retrospective analysis of cardiac catheterization data from 85 DS infants and 85 controls with congenital heart disease and PAH.
  • Comparison of pulmonary arterial resistance (Rp) and compliance (Cp) before and after corrective surgery.
  • Multivariate logistic regression analysis to identify predictors of postoperative home oxygen therapy (HOT).

Main Results:

  • Preoperative pulmonary compliance (Cp) was significantly lower in DS patients compared to controls.
  • No significant differences in mean pulmonary arterial pressure or pulmonary arterial resistance (Rp) were observed preoperatively.
  • Postoperative regression analysis showed a downward shift in the Rp-Cp relationship in DS patients, and low preoperative Cp and DS were significant predictors of postoperative HOT.

Conclusions:

  • Individuals with Down syndrome possess distinct pulmonary vasculature characterized by low pulmonary compliance (Cp).
  • Low preoperative pulmonary compliance (Cp) is a significant predictor of the need for postoperative home oxygen therapy (HOT) in DS patients.
  • These findings highlight unique pulmonary vascular characteristics in DS that influence postoperative management.

Related Concept Videos

Relationship Formation02:12

Relationship Formation

What do you think is the single most influential factor in determining with whom you become friends and whom you form romantic relationships? You might be surprised to learn that the answer is simple: the people with whom you have the most contact. This most important factor is proximity. You are more likely to be friends with people you have regular contact with. For example, there are decades of research that shows that you are more likely to become friends with people who live in your dorm,...
46.2K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
595
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
464
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
495
Ending Relationships01:28

Ending Relationships

The dissolution of intimate relationships presents complex emotional and psychological challenges, particularly when emotional bonds are strong, the relationship is long-standing, and perceived alternatives are limited. This distress often intensifies in romantic breakups, where the initiator may experience greater turmoil than the rejected partner. Contributing factors include residual attachment, guilt over causing pain, and uncertainty about how to manage the situation. The stress is further...
181
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
612